From Nasdaq: 2025-02-24 16:28:00

Zacks Research Daily presents new reports on major stocks like Alibaba Group Holding Ltd. (BABA), Pfizer Inc. (PFE), MercadoLibre, Inc. (MELI), and micro-cap stock SIFCO Industries, Inc. (SIF). Alibaba’s Q3 fiscal 2025 results were positive, while Pfizer saw growth in non-COVID operational revenue. MercadoLibre reported impressive Q4 2024 results with rising revenues and earnings. SIFCO Industries achieved a 20.5% revenue increase in fiscal 2024.

Alibaba’s shares have outperformed the Zacks Internet – Commerce industry, with strong momentum in its international commerce retail business. Pfizer’s revenue growth improved, driven by key in-line products. MercadoLibre’s accelerating commerce and fintech revenues contributed to its success, while SIFCO Industries achieved growth driven by strong demand in aerospace and energy.

Alibaba, Pfizer, MercadoLibre, and SIFCO Industries have seen positive growth, with Alibaba’s international commerce retail business driving momentum. Pfizer’s revenue growth was driven by key products, while MercadoLibre saw rising revenues and earnings. SIFCO Industries achieved a revenue increase in fiscal 2024 due to strong demand in aerospace and energy sectors.

Other noteworthy reports feature Anheuser-Busch InBev SA/NV (BUD), Altria Group, Inc. (MO), and Constellation Energy Corp. (CEG). Altria benefits from robust pricing actions, while Live Nation is expected to benefit from pent-up demand for live events. State Street is supported by relatively higher rates and business servicing wins. Cincinnati Financial’s revenue growth is driven by progress in the Commercial Lines segment. Hologic’s recent acquisitions have boosted revenue growth.



Read more at Nasdaq: Top Research Reports for Alibaba, Pfizer & MercadoLibre